Edwards Lifesciences (EW) Tops Q2 EPS by 20c; Raises Outlook

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/20/2026

1. SPY
2. ZION
3. BRZE
4. META
5. MMM
6. RAPP
7. IBM
8. AMZN
9. IRON
10. TSLA

Go back to Edwards Lifesciences (EW) Tops Q2 EPS by 20c; Raises Outlook

Edwards Lifesciences Reports Second Quarter Results

July 26, 2017 4:15 PM EDT

IRVINE, Calif., July 26, 2017 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today reported financial results for the quarter ended June 30, 2017. 

Second Quarter and Recent Highlights:

Sales grew 11 percent to $842 million; underlying1 sales increased 15 percent to $864 million Global THVT sales grew 16 percent to $488 million; underlying sales increased 23 percent U.S. THVT sales grew 28 percent to $316 million EPS was $0.86, an increase of 48 percent; adjusted2... More